- In March 2024, Koninklijke Philips N.V. (Netherlands) announced an expanded collaboration with AWS to address the increasing demand for secure, scalable digital pathology solutions in the cloud. In this partnership, the goal is to enhance workflow efficiency and facilitate seamless integration with existing healthcare systems to enable comprehensive patient care
- In February 2024, Roche announced its collaboration with Path AI to develop AI-powered digital pathology algorithms for companion diagnostics. In this partnership, Roche aims to accelerate its ability to meet the needs of biopharma companies seeking AI-driven companion diagnostic solutions and end-to-end services
- In October 2023, Pramana and Gestalt introduced an integrated AI-powered platform and digital pathology solutions that combine digital pathology, AI, image analysis, and DICOM into a single comprehensive offering
- In February 2022, GlobalMedia Group, LLC announced that it had received the CE mark for its ClinicalAccess Station Lite, eNcounter telehealth software suite, and various diagnostic examination cameras. In this regulatory certification, the company was able to expand its services to the European Union and offer telehealth solutions within European markets
- In May 2020, Leica Biosystems launched the Aperio GT 450 DX, its next-generation digital pathology scanner, in the Asia-Pacific region. In this system, which features continuous packing, touch-free operation, and a 32-second scan time at 40x magnification, was registered as CE IVD and TGA. In this way, it allows healthcare organizations to scale up their digital pathology capabilities to meet increasing demands without compromising quality. In the testing phase, the Aperio GT 450 DX was evaluated by technicians and pathologists, including those at Seoul National University Hospital (SNUH), a leading digital pathology facility in South Korea, to assess its impact on workflow
Frequently Asked Questions
The market is segmented based on Segmentation, By Systems (Dynamic, Static, and Hybrid), Application (Diagnosis, Education, Research, and Others), End User (Hospitals, Diagnostic Centers and Pathology Clinics, Pharmaceutical and Biotech Companies, Academic Institutes, and Research Organizations) – Industry Trends and Forecast to 2032
.
The Global Telepathology Service Market size was valued at USD 1.08 USD Billion in 2024.
The Global Telepathology Service Market is projected to grow at a CAGR of 11.24% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
